"Designing Growth Strategies is in our DNA"

Tardive Dyskinesia Therapeutics Market Size, Share & Industry Analysis, By Drug (Deutetrabenazine, Valbenazine, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI107532

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Tardive Dyskinesia, By Key Countries, 2025
    2. Key Industry Developments
    3. Pipeline Analysis
    4. Economic Cost Burden for the Treatment of Tardive Dyskinesia
    5. Regulatory & Reimbursement Scenario, By Key Regions
    6. Impact of COVID-19 on the Market
  5. Global Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Region
      1. U.S.
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. U.S. Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  7. Europe Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
  8. Asia Pacific Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Neurocrine Biosciences, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Mitsubishi Chemical Group Corporation.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. SOM BIOTECH
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Luye Pharma Group
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Tardive Dyskinesia, By Key Countries, 2025
    2. Key Industry Developments
    3. Pipeline Analysis
    4. Economic Cost Burden for the Treatment of Tardive Dyskinesia
    5. Regulatory & Reimbursement Scenario, By Key Regions
    6. Impact of COVID-19 on the Market
  5. Global Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Region
      1. U.S.
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. U.S. Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  7. Europe Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
  8. Asia Pacific Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Neurocrine Biosciences, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Mitsubishi Chemical Group Corporation.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. SOM BIOTECH
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Luye Pharma Group
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1:  Global Tardive Dyskinesia Therapeutics Market Value Share (%), By Drug, 2025 & 2034

Figure 2:  Global Tardive Dyskinesia Therapeutics Market Value Share (%), By Distribution Channel, 2025 & 2034

Figure 3:  Global Tardive Dyskinesia Therapeutics Market Value Share (%), By Country/Region, 2025 & 2034

Figure 4:  U.S. Tardive Dyskinesia Therapeutics Market Value (USD billion), by Drug, 2025 & 2034

Figure 5:  U.S. Tardive Dyskinesia Therapeutics Market Value Share (%), by Drug, 2025

Figure 6:  U.S. Tardive Dyskinesia Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 7:  U.S. Tardive Dyskinesia Therapeutics Market Value Share (%), by Distribution Channel, 2025

Figure 8:  Europe Tardive Dyskinesia Therapeutics Market Value (USD billion), by Drug, 2025 & 2034

Figure 9:  Europe Tardive Dyskinesia Therapeutics Market Value Share (%), by Drug, 2025

Figure 10:  Europe Tardive Dyskinesia Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 11:  Europe Tardive Dyskinesia Therapeutics Market Value Share (%), by Distribution Channel, 2025

Figure 12:  Europe Tardive Dyskinesia Therapeutics Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 13:  Europe Tardive Dyskinesia Therapeutics Market Value Share (%), by Country/ Sub-Region, 2025

Figure 14:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value (USD billion), by Drug, 2025 & 2034

Figure 15:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value Share (%), by Drug, 2025

Figure 16:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 17:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value Share (%), by Distribution Channel, 2025

Figure 18:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 19:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value Share (%), by Country/ Sub-Region, 2025

Figure 20:  Rest of the World Tardive Dyskinesia Therapeutics Market Value (USD billion), by Drug, 2025 & 2034

Figure 21:  Rest of the World Tardive Dyskinesia Therapeutics Market Value Share (%), by Drug, 2025

Figure 22:  Rest of the World Tardive Dyskinesia Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 23:  Rest of the World Tardive Dyskinesia Therapeutics Market Value Share (%), by Distribution Channel, 2025

Table 1:  Global Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Drug, 2021-2034

Table 2:  Global Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 3:  Global Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Country/Region, 2021-2034

Table 4:  U.S. Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Drug, 2021-2034

Table 5:  U.S. Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 6:  Europe Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Drug, 2021-2034

Table 7:  Europe Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 8:  Europe Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 9:  Asia Pacific Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Drug, 2021-2034

Table 10:  Asia Pacific Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 11:  Asia Pacific Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 12:  Rest of the World Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Drug, 2021-2034

Table 13:  Rest of the World Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Tardive Dyskinesia Therapeutics Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 101
Download Free Sample

    man icon
    Mail icon
    Captcha refresh

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Get 20% Free Customization On This Report
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports